Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel C. Martin Insider Profile
4 Followers
Daniel C. Martin, CCO at Deciphera Pharmaceuticals, holds 55.12K shares in Deciphera Pharmaceuticals (Ticker: DCPH).
Profitable Transactions
0 out of 7 Profitable Transactions
Average Return
-62.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel C. Martin's holdings
Insider Roles
CCO
Roles that Daniel C. Martin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 17, 2023 - Feb 17, 2024
Return:-5.50%
The most profitable trade made by Daniel C. Martin
Daniel C. Martin's Trading History
List of latest transactions for each holding click on a transaction to see Daniel C. Martin's performance on stock
You May Also Like
Daniel C. Martin insider profile FAQ
What is the percentage of profitable transactions made by Daniel C. Martin?
The percentage of profitable transactions made by Daniel C. Martin is 0%.
What is the average return per transaction made by Daniel C. Martin?
The average return per transaction made by Daniel C. Martin is -62.50%.
What stocks does Daniel C. Martin hold?
Daniel C. Martin holds: DCPH stocks.
What was Daniel C. Martin’s latest transaction?
Daniel C. Martin latest transaction was an Uninformative Buy of ―.
What was Daniel C. Martin's most profitable transaction?
Daniel C. Martin’s most profitable transaction was an Informative Sell of DCPH stock on February 17, 2023. The return on the trade was -5.50%.
What is Daniel C. Martin's role in Deciphera Pharmaceuticals?
Daniel C. Martin's role in Deciphera Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.